Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04150705 · ClinicalTrials.gov registry record · NA
PET/MR for Rectal Cancer Treatment Monitoring and Surveillance
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04150705 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 14 participants.
The verdict
NCT04150705, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The goal of pilot study is to assess the feasibility of FDG-PET/MRI for monitoring rectal cancer disease status in the setting of rectal cancer non-operative management (NOM). Data from this study will be used to guide the design of future clinical trials involving FDG-PET/MRI for rectal cancer NOM.
Interventions
- DEVICE FDG PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2022-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04150705
The ClinicalTrials.gov registry entry for NCT04150705 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDG PET/MRI is the first listed.
NCT04150705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04150705 about?
NCT04150705 is a clinical study titled "PET/MR for Rectal Cancer Treatment Monitoring and Surveillance". The goal of pilot study is to assess the feasibility of FDG-PET/MRI for monitoring rectal cancer disease status in the setting of rectal cancer non-operative management (NOM). Data from this study will be used to guide the design of future clinical trials involving FDG-PET/MRI for rectal cancer NOM.
What is the current status of trial NCT04150705?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2020-06-01. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04150705?
The interventions under investigation include: FDG PET/MRI (DEVICE).
Who is sponsoring clinical trial NCT04150705?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.